Here is the reason for the rapid price rise:Pacific Edge Limited [NZX
EB] has enjoyed a dream run in trading today, emerging as the star performer on the New Zealand Stock Exchange.
Pacific Edge — established in 2001 — is a cancer-diagnostics company founded in Dunedin. They specialise in genetic-biomarker testing known as CxBladder. This process is non-invasive and able to detect the presence of cancerous cells in urine.
Pacific Edge’s share price is currently $0.23, and it has a market capitalisation of $93.79 million.
Why has the [NZX: PEB] share price surged today?
Pacific Edge made an announcement today that sparked much excitement:
- It is partnering with US healthcare giant Kaiser Permanente.
- The goal is to roll out commercial use of its patented CxBladder tests.
- Kaiser Permanente patients will be able to provide a urine sample for delivery to Pacific Edge for analysis and reporting.
- The ability for non-invasive, regular testing will benefit both patients and physicians in the long-run.
Pacific Edge CEO David Darling has remarked:
‘We are delighted to be working with Kaiser Permanente to implement the delivery of CxBladder into their patient care program for urology. This outcome highlights Kaiser Permanente’s recognised position as an industry leader in their approach to high-quality healthcare, innovation and value-based medicine.’
Naturally enough, news of this partnership has buoyed investor sentiment. Today’s buy-in for Pacific Edge stocks has been rapid and enthusiastic.
- Forums
- ASX - By Stock
- PEB
- LCD Meeting next week to consider "Prognostic and Predictive Molecular Classifier for Bladder Cancer"
LCD Meeting next week to consider "Prognostic and Predictive Molecular Classifier for Bladder Cancer", page-4
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PEB (NZSX) to my watchlist
|
|||||
Last
10.3¢ |
Change
0.003(3.00%) |
Mkt cap ! n/a |
Open | High | Low | Value | Volume |
10.0¢ | 10.3¢ | 10.0¢ | $15.66K | 154.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
0 | 29058 | 10.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.3¢ | 93551 | 0 |
Last trade - 13.00pm 30/08/2024 (20 minute delay) ? |
Featured News
PEB (NZSX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online